News - South America, Biotechnology


Popular Filters

1 to 25 of 29 results

Seattle Genetics earns $6 million milestone under Adcetris accord with Takeda

Seattle Genetics earns $6 million milestone under Adcetris accord with Takeda


US biotech firm Seattle Genetics says it will receive milestone payments from Japan’s Takeda Pharmaceutical…

AdcetrisAsia-PacificBiotechnologyFinancialMarkets & MarketingOncologySeattle GeneticsSouth AmericaTakeda Pharmaceuticals

Brazil’s Cristalia gains ANVISA approval for production of biosimilar drugs


The Brazilian drugmaker Cristalia has just taken another step towards its goal of producing biosimilar…

Anti-Arthritics/RheumaticsBiosimilarsBiotechnologyBrazilCristaliaEnbrelHerceptinMetabolicsNorditropinOncologyProductionRegulationSouth America

10 billion real to be invested in Brazil’s production of biotech drugs by 2016

10 billion real to be invested in Brazil’s production of biotech drugs by 2016


Brazil's Development Bank (BNDS) plans to invest up to 10 billion real ($4.2 billion) in the production…

BiotechnologyBrazilFinancialGenericsHypermarcasMarkets & MarketingProductionSanofiSouth America

Biologics reimbursement trends in Argentina, Brazil and Mexico

Biologics reimbursement trends in Argentina, Brazil and Mexico


Novel biologics must demonstrate improvements in efficacy, safety and cost-benefit compared with currently…

Anti-Arthritics/RheumaticsArgentinaBiotechnologyBrazilMalaysiaMarkets & MarketingOncologyPricingSouth America

BNDES invests 804 million real in Novartis' new Brazil biotechnology unit

BNDES invests 804 million real in Novartis' new Brazil biotechnology unit


The Brazilian Development Bank will finance 804 million real ($342 million) for the construction of a…

BexseroBiotechnologyBrazilFinancialNovartisProductionSouth AmericaVaccines

Brazil’s MoH partners with Merck Serono to invest $430 million in bio-pharma production

Brazil’s MoH partners with Merck Serono to invest $430 million in bio-pharma production


The Brazilian Ministry of Health is managing a series of product development partnerships and the selection…

Anti-Arthritics/RheumaticsBionovisBiotechnologyFinancialMerck KGaAMerck SeronoOncologyProductionSouth America

Briefs: BioMarin files Vimizim in Brazil; Kyowa Hakko submits KRN125 in Japan; Insmed's Arikace update


USA-based BioMarin Pharmaceutical (Nasdaq: BMRN) has submitted the Vimizim (BMN-110, elosulfase alfa)…

Asia-PacificBioMarin PharmaceuticalBiotechnologyInsmedKRN125Kyowa Hakko KirinPharmaceuticalRegulationResearchSouth AmericaVimizim

New long term biotech research cooperation deal signed by Brazil and UK


The British Biotechnology and Biological Sciences Research Council (BBSRC) and the Brazilian National…

BiotechnologyEuropeResearchSouth America

Market access barriers for multinationals, but Argentina still offers attractive pharma opportunities


Several barriers impede market access but the regulatory landscape in Argentina is changing and attractive…

BiotechnologyMarkets & MarketingPatentsPharmaceuticalRegulationSouth America

Sinovac Biotech flu vaccine OKed in Mexico; EV71 results; financials


In what was a busy news day for Sinovac Biotech (Nasdaq: SVA), a leading provider of vaccines in China,…

BiotechnologyEV71FinancialRegulationResearchSinovac BiotechSouth America

Briefs: Merz Pharma pulls out of Obagi bid; Aubagio approved in Argentina


German family-owned Merz Pharma says that it has withdrawn its non-binding proposal to acquire all of…

AubagioBiotechnologyGenzymeMergers & AcquisitionsMerz PharmaceuticalsObagi Medical ProductsPharmaceuticalRegulationSanofiSouth AmericaValeant Pharmaceuticals

Pfizer and Protalix' Gaucher drug Uplyso approved in Brazil


US drugs behemoth Pfizer (NYSE: PFE) and Israel-based Protalix BioTherapeutics (NYSE MKT:PLX) said that…

BiotechnologyElelysoPfizerPharmaceuticalProtalix BioTherapeuticsRare diseasesRegulationSouth AmericaUplyso

Russia's Biocad plans to produce high-tech drugs in Brazil


Biocad, one of Russia's leading biotechnology companies, plans to launch production of several of its…

AvastinBiocadBiotechnologyGenericsHerceptinMabTheraOncologyProductionRocheSouth America

Call for strong Trans-Pacific intellectual property framework from PhRMA


The Pharmaceutical Research and Manufacturers of America (PhRMA) this week called on nations participating…

Asia-PacificBiotechnologyNorth AmericaPatentsPharmaceuticalSouth America

Brazil's federal government plans to invest in scientific research and biotechnology


The federal government in Brazil has announced plans to invest in the consolidation of a program focused…

BiotechnologyFinancialResearchSouth America

Tranzyme exploring options, including sale of the firm; is Ache up for sale?


Following two recent R&D pipeline disappointments, the board of directors of US biotech firm Tranzyme…

Ache Laboratorios FarmaceuticosBiotechnologyMergers & AcquisitionsNorth AmericaPharmaceuticalSouth AmericaTranzyme

News briefs on Ipsen/Galderma and YM BioSciences nimotuzumab assets


French drugmaker Ipsen (Euronext: IPN) and Switzerland-headquartered Galderma have expanded their collaboration…

Asia-PacificBiotechnologyCIMABDysportGaldermaInnoKeys PTEIpsenLicensingnimotuzumabOncologyPharmaceuticalSouth AmericaYM Biosciences

Cuba sets up pharmaceutical industry group


Cuba announced the setting up of BioCubaFarma, the Biotechnological and Pharmaceutical Industry Group,…

BiotechnologyMarkets & MarketingPharmaceuticalSouth America

Brazilian generic industry review


The Brazilian pharmaceutical market is growing rapidly into one of the largest pharma markets in the…

BiotechnologyGenericsMarkets & MarketingSouth America

South and Central America API market closing gap on northern neighbors


The market for active pharmaceutical ingredients (API) t in the Americas was worth a staggering $46 billion…

BiotechnologyGenericsMarkets & MarketingNorth AmericaSouth America

Latin America progress and challenges in expanding access to HIV treatment highlighted by PAHO


A number of countries in Latin America and the Caribbean - including Argentina, Brazil, Chile, Cuba,…

Anti-viralsBiotechnologyHealthcarePharmaceuticalSouth America

New biologics and biosimilars approval guidelines in Mexico


In Mexico, new guidelines are now in effect for the market authorization of biologics and biosimilars,…

BiotechnologyGenericsRegulationSouth America

1 to 25 of 29 results

Back to top